Sonic Healthcare Research and Development Expenses 2023-2023 | SKHHY
Sonic Healthcare annual/quarterly research and development expenses history and growth rate from 2023 to 2023. Research and development expenses can be defined as an expense arising from studies and product development processes.
- Sonic Healthcare research and development expenses for the quarter ending December 31, 2023 were $M, a NAN% increase year-over-year.
- Sonic Healthcare research and development expenses for the twelve months ending December 31, 2023 were $0M, a NAN% increase year-over-year.
- Sonic Healthcare annual research and development expenses for 2023 were $0B, a NAN% decline from 2022.
- Sonic Healthcare annual research and development expenses for 2022 were $0B, a NAN% decline from 2021.
- Sonic Healthcare annual research and development expenses for 2021 were $0B, a NAN% decline from .
| Sonic Healthcare Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023 | $ |
| 2022 | $ |
| 2021 | $0 |
| Sonic Healthcare Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023-12-31 | |
| 2023-06-30 | |
| 2022-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $8.426B | $5.499B |
| Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services and their collective patients. Sonic Healthcare Limited is based in Sydney, Australia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $122.556B | 15.38 |
| Cencora (COR) | United States | $47.310B | 18.44 |
| ICON (ICLR) | Ireland | $26.285B | 24.82 |
| DiDi Global (DIDIY) | China | $21.823B | 0.00 |
| Avantor (AVTR) | United States | $14.665B | 21.59 |
| CochLear (CHEOY) | Australia | $14.459B | 0.00 |
| Natera (NTRA) | United States | $13.261B | 0.00 |
| Revvity (RVTY) | United States | $13.239B | 23.22 |
| Medpace Holdings (MEDP) | United States | $12.486B | 41.08 |
| Viatris (VTRS) | United States | $11.966B | 3.58 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.394B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.807B | 20.69 |
| Solventum (SOLV) | United States | $9.209B | 0.00 |
| HealthEquity (HQY) | United States | $7.373B | 47.34 |
| Organon (OGN) | United States | $5.233B | 4.96 |
| Bausch + Lomb (BLCO) | Canada | $5.186B | 20.76 |
| Doximity (DOCS) | United States | $5.110B | 35.79 |
| PACS (PACS) | United States | $4.461B | 0.00 |
| Life Times (LTH) | United States | $3.655B | 38.29 |
| Sotera Health (SHC) | United States | $3.210B | 15.75 |
| Surgery Partners (SGRY) | United States | $3.184B | 29.13 |
| GoodRx Holdings (GDRX) | United States | $3.062B | 116.57 |
| Agilon Health (AGL) | United States | $2.772B | 0.00 |
| Progyny (PGNY) | United States | $2.450B | 42.18 |
| NovoCure (NVCR) | Jersey | $2.092B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.996B | 7.91 |
| Premier (PINC) | United States | $1.906B | 8.15 |
| BrightSpring Health Services (BTSG) | United States | $1.802B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.711B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.444B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.197B | 0.00 | |
| CareDx (CDNA) | United States | $0.733B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.721B | 0.00 |
| Embecta (EMBC) | United States | $0.719B | 4.89 |
| Pediatrix Medical (MD) | United States | $0.649B | 6.88 |
| Auna S.A (AUNA) | Luxembourg | $0.592B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 15.27 |
| InnovAge Holding (INNV) | United States | $0.575B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.440B | 0.00 |
| Enhabit (EHAB) | United States | $0.435B | 43.40 |
| ModivCare (MODV) | United States | $0.381B | 7.12 |
| Sonida Senior Living (SNDA) | United States | $0.379B | 0.00 |
| LifeMD (LFMD) | United States | $0.327B | 0.00 |
| DocGo (DCGO) | United States | $0.318B | 17.39 |
| Sharecare (SHCR) | United States | $0.290B | 0.00 |
| MultiPlan (MPLN) | United States | $0.246B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.237B | 0.00 |
| Beauty Health (SKIN) | United States | $0.223B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.189B | 0.00 |
| Biodesix (BDSX) | United States | $0.185B | 0.00 |
| So-Young (SY) | China | $0.107B | 51.51 |
| Pono Capital Two (PTWO) | United States | $0.071B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.048B | 0.00 |
| NeueHealth (NEUE) | United States | $0.044B | 5.88 |
| IceCure Medical (ICCM) | Israel | $0.036B | 0.00 |
| Oncology Institute (TOI) | United States | $0.030B | 0.00 |
| Nutex Health (NUTX) | United States | $0.027B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.024B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.023B | 0.00 |
| OncoCyte (OCX) | United States | $0.022B | 0.00 |
| KindlyMD (KDLY) | $0.016B | 0.00 | |
| BIMI Holdings (BIMI) | United States | $0.016B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.005B | 0.00 |
| DermTech (DMTK) | United States | $0.005B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.003B | 0.00 |
| OpGen (OPGN) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Assure Holdings (IONM) | United States | $0.001B | 0.00 |